Data Shows Treatment with Janssens Stelara Reduced Rates of Hospitalization and Surgery in ModeratetoSevere Crohns Disease

WASHINGTON DC&8211;BUSINESS WIRE&8211;The Janssen Pharmaceutical Companies of Johnson &38; Johnson announced today a new analysis looking at twoyear data from the IMUNITI longterm extension LTE STELARAÂÂustekinumab programme which demonstrated ...